Previous 10 |
home / stock / hbp:cc / hbp:cc news
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company") today announces, with great sadness, the sudden passing of its Interim Chief Executive Officer and Chairman of the Board of Directors (the "Board"), Prof. Dr. S Slawomir Majewski. Dr...
News, Short Squeeze, Breakout and More Instantly...
Helix BioPharma Corp. Company Name:
HBP:CC Stock Symbol:
TSXC Market:
Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2025 Haivision Systems Inc. (HAI:CA) is expected to report for Q2 2024 Peyto Exploration & Development Corp. (PEY:CA) is expected to report $0....
Batero Gold Corp. (BAT:CA) is expected to report for Q2 2024 Barrick Gold Corporation (ABX:CA) is expected to report $0.22 for Q1 2024 Exco Technologies Limited (XTC:CA) is expected to report $0.17 for Q2 2024 Amerigo Resources Ltd. (ARG:CA) is expected to report for Q1 2024 Parkl...
Wall Financial Corporation (WFC:CA) is expected to report for quarter end 2024-01-31 Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 Choice Properties Real Estate Investment Trust (CHP.UN:CA) is expected to report $0.26 for Q1 2024 Celestica Inc. Subordinate Voting Sh...